FGFR4 and Obesity: To evaluate the dose dependency of the anti-obesity effect induced by antisense reduction of FGFR4 expression, DIO mice were treated with FGFR4 ASO #1 at 25, 50 and 75 mg/kg/week for 13 weeks.